美国食品药品监督管理局发布警示前后阿片类药物与苯二氮䓬类药物联合使用情况
Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.
机构信息
School of Management, Yale University, New Haven, Connecticut.
New York State Psychiatric Institute, Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York.
出版信息
JAMA Psychiatry. 2019 Nov 1;76(11):1208-1210. doi: 10.1001/jamapsychiatry.2019.2563.
Abstract
This case series study provides a national estimate of opioid and benzodiazepine coprescribing before and after the US Food and Drug Administration (FDA) boxed warning.
摘要
本病例系列研究提供了美国食品和药物管理局（FDA）发布盒装警告前后阿片类药物和苯二氮䓬类药物联合使用的全国估计数据。
相似文献
1
Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.美国食品药品监督管理局发布警示前后阿片类药物与苯二氮䓬类药物联合使用情况
JAMA Psychiatry. 2019 Nov 1;76(11):1208-1210. doi: 10.1001/jamapsychiatry.2019.2563.
2
FDA Boxed Warning for Immediate-Release Opioids.美国食品药品监督管理局（FDA）对速释阿片类药物的黑框警告。
J Pain Palliat Care Pharmacother. 2016 Jun;30(2):141-5. doi: 10.3109/15360288.2016.1173762.
3
Patterns in Outpatient Benzodiazepine Prescribing in the United States.美国门诊苯二氮䓬类药物处方模式。
JAMA Netw Open. 2019 Jan 4;2(1):e187399. doi: 10.1001/jamanetworkopen.2018.7399.
4
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统，八个州，2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
5
FDA requires boxed warning for all immediate-release opioid products.美国食品药品监督管理局要求对所有速释阿片类产品加框警示。
Am J Health Syst Pharm. 2016 May 1;73(9):e114-5. doi: 10.2146/news160026.
6
Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.1996 - 2013年美国苯二氮䓬类药物处方量增加与过量用药死亡率上升
Am J Public Health. 2016 Apr;106(4):686-8. doi: 10.2105/AJPH.2016.303061. Epub 2016 Feb 18.
7
Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.政策制定与评估相结合——以阿片类药物危机为例。
N Engl J Med. 2017 Dec 14;377(24):2306-2309. doi: 10.1056/NEJMp1710014.
8
Opioid prescriptions in England doubled over 12 years, study shows.研究显示，英格兰的阿片类药物处方量在12年间增加了一倍。
BMJ. 2017 Sep 13;358:j4249. doi: 10.1136/bmj.j4249.
9
Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016.2016 年疾病预防控制中心发布指南后，医生同时开处阿片类药物和苯二氮䓬类药物的比率。
JAMA Netw Open. 2019 Aug 2;2(8):e198325. doi: 10.1001/jamanetworkopen.2019.8325.
10
Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: "Holy Trinity" prescribing in the state of Florida.阿片类药物、苯二氮䓬类药物和卡马西平的重叠处方：佛罗里达州的“三位一体”处方。
Drug Alcohol Depend. 2019 Dec 1;205:107693. doi: 10.1016/j.drugalcdep.2019.107693. Epub 2019 Oct 28.
引用本文的文献
1
Predictors of Incident Benzodiazepine Co-prescription Among Patients Prescribed Long-term Opioids.长期使用阿片类药物患者中苯二氮䓬类药物联合处方事件的预测因素
J Gen Intern Med. 2025 Jul 16. doi: 10.1007/s11606-025-09712-2.
2
Central nervous system active medication use in Medicare enrollees receiving home health care: association with chronic pain and anxiety level.接受家庭医疗护理的医疗保险参保者使用中枢神经系统活性药物情况：与慢性疼痛和焦虑水平的关联
Pain. 2025 Jan 1;166(1):123-129. doi: 10.1097/j.pain.0000000000003331. Epub 2024 Jul 10.
3
Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study.描述新处方镇静催眠药物使用者中偶发性阿片类药物使用情况：一项全国队列研究。
BMJ Open. 2024 May 30;14(5):e082339. doi: 10.1136/bmjopen-2023-082339.
4
Effects of comprehensive medication review on opioid overuse among medicare beneficiaries.综合药物审查对医疗保险受益人中阿片类药物过度使用的影响。
J Pharm Health Serv Res. 2024 Feb 28;15(1):rmae002. doi: 10.1093/jphsr/rmae002. eCollection 2024 Mar.
5
Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999-2018.在阿片类药物泛滥期间，1999-2018 年美国白人和黑人的多种物质导致的死亡率趋势。
BMC Public Health. 2024 Jan 7;24(1):112. doi: 10.1186/s12889-023-17563-x.
6
Association Between Concurrent Use of Benzodiazepines and Opioids and Health Care Utilization Among Patients With Cancer in Puerto Rico.波多黎各癌症患者同时使用苯二氮䓬类药物和阿片类药物与医疗保健利用之间的关联。
JCO Glob Oncol. 2023 Sep;9:e2300008. doi: 10.1200/GO.23.00008.
7
Understanding the rise in overdose deaths involving opioids and non-opioid prescription drugs in the United States.了解美国涉及阿片类药物和非阿片类处方药的过量用药死亡人数上升情况。
Int J Drug Policy. 2023 Jul 6:104104. doi: 10.1016/j.drugpo.2023.104104.
8
Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures.儿科无人监管药物暴露急诊就诊趋势。
Am J Prev Med. 2023 Jun;64(6):834-843. doi: 10.1016/j.amepre.2023.01.011. Epub 2023 Apr 20.
9
Sedative-hypnotic Co-prescribing with Opioids in a Large Network of Community Health Centers.在大型社区医疗中心网络中，镇静催眠药物与阿片类药物的联合处方。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319221147378. doi: 10.1177/21501319221147378.
10
A descriptive analysis of concomitant opioid and benzodiazepine medication use and associated adverse drug events in United States adults between 2009 and 2018.2009年至2018年间美国成年人同时使用阿片类药物和苯二氮卓类药物及其相关药物不良事件的描述性分析。
Explor Res Clin Soc Pharm. 2022 Mar 20;5:100130. doi: 10.1016/j.rcsop.2022.100130. eCollection 2022 Mar.
本文引用的文献
1
Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline.美国疾病预防控制中心 2016 年阿片类药物指南发布前后的阿片类药物处方情况。
Ann Intern Med. 2018 Sep 18;169(6):367-375. doi: 10.7326/M18-1243. Epub 2018 Aug 28.
2
Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.2002 - 2014年阿片类药物与苯二氮䓬类药物联合处方趋势
Am J Prev Med. 2016 Aug;51(2):151-160. doi: 10.1016/j.amepre.2016.02.014. Epub 2016 Apr 11.
3
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
4
Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.美国接受阿片类镇痛药的退伍军人中苯二氮䓬类药物的处方模式与药物过量死亡情况：病例队列研究
BMJ. 2015 Jun 10;350:h2698. doi: 10.1136/bmj.h2698.
Zotero 插件